Detection of Liver Fibrosis Using Advanced MRI Methods

ID Number 09-1187

Principal Investigator(s)
Bachir Taouli

Department(s) or Division(s)


Patients with hepatitis C virus infection (HCV) are at high risk of developing liver scarring (fibrosis), with ultimate risks of cirrhosis and liver cancer that may require liver transplant. We would like to develop non invasive advanced MRI techniques (diffusion and dynamic contrast-enhanced MRI) to assess the degree of liver damage in HCV. These techniques combined could reach high diagnostic performance for detection of liver fibrosis; and could decrease the number of necessary liver biopsies, which have risks and sample only a small portion of the liver.

Contact Information
Lena Marra
212 241-9369

Recruiting Patients: Yes